146
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Chronic Atopic Dermatitis with Eosinophilia Improved by Daesiho-Tang: A Case Report

, ORCID Icon, , &
Pages 2561-2572 | Received 06 Jun 2023, Accepted 03 Sep 2023, Published online: 20 Sep 2023

References

  • Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis: pathogenetic mechanisms. Clin Exp Dermatol. 2008;25(7):530–534. doi:10.1046/j.1365-2230.2000.00699.x
  • Grewe M, Bruijnzeel-Koomen CAFM, Schöpf E, et al. A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today. 1998;19(8):359–361. doi:10.1016/S0167-5699(98)01285-7
  • Furue M, Ulzii D, Vu Y, Tsuji G, Kido-Nakahara M, Nakahara T. Pathogenesis of atopic dermatitis: current Paradigm. Iran J Immunol. 2019;16(2):97–107. doi:10.22034/IJI.2019.80253
  • Mita S, Tominaga A, Takatsu K, Suda T. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med. 1988;167(5):1737–1742. doi:10.1084/jem.167.5.1737
  • Simon D, Braathen LR, Simon HU. Eosinophils and atopic dermatitis. Allergy. 2004;59(6):561–570. doi:10.1111/j.1398-9995.2004.00476.x
  • Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2015;70(2):338–351. doi:10.1016/j.jaad.2013.10.010
  • Carroll CL, Balkrishnan R, Feldman SR, Fleischer AB Jr, Manuel JC. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol. 2005;22(3):192–199. doi:10.1111/j.1525-1470.2005.22303.x
  • Mastorino L, Viola R, Panzone M, et al. Dupilumab induces a rapid decrease of pruritus in adolescents: a pilot real-life study. Dermatol Ther. 2021;34(6):e15115. doi:10.1111/dth.15115
  • Hussain Z, Thu HE, Shuid AN, Kesharwani P, Khan S, Hussain F. Phytotherapeutic potential of natural herbal medicines for the treatment of mild-to-severe atopic dermatitis: a review of human clinical studies. Bio Pharmaco. 2017;93:596–608. doi:10.1016/j.biopha.2017.06.087
  • Ikegami F, Sumino M, Fujii Y, Akiba T, Satoh T. Pharmacology and toxicology of Bupleurum root-containing Kampo medicines in clinical use. Hum Exp Toxicol. 2006;25(8):481–494. doi:10.1191/0960327106het654oa
  • Da X, Talahasjo H, Hein KZ, Morita E. In vitro antifungal activity of kampo medicine water extracts against Trichophyton rubrum. Nat Prod Commun. 2016;11(6):763–766. doi:10.1177/1934578X1601100616
  • Sato N, Li W, Takemoto H, et al. Comprehensive evaluation of antioxidant effects of Japanese Kampo medicines led to identification of Tsudosan formulation as a potent antioxidant agent. J Nat Med. 2019;73:163–172. doi:10.1007/s11418-018-1259-x
  • Zhang Z, Leng Y, Fu X, et al. The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis. Front Pharmacol. 2022;13:918681. doi:10.3389/fphar.2022.918681
  • Hussain A, Yadav MK, Bose S, et al. Daesiho-Tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota. PLoS One. 2016;11:e0165483. doi:10.1371/journal.pone.0165483
  • Qian W, Cai X, Zhang X, Wang Y, Qian Q, Hasegawa J. Effect of Daisaikoto on expressions of SIRT1 and NF-kappaB of diabetic fatty liver rats induced by high-fat diet and streptozotocin. Yonago Acta Med. 2016;59(2):149–158.
  • Umeda M, Amagaya S, Ogihara Y. Effect of shosaikoto, daisaikoto and sannoshashinto (traditional Japanese and Chinese medicines) on experimental hyperlipidemia in rats. J Ethnopharmacol. 1989;26(3):255–269. doi:10.1016/0378-8741(89)90098-6
  • European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology. 1993;186:23–31. doi:10.1159/000247298
  • Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–216. doi:10.1111/j.1365-2230.1994.tb01167.x
  • Wickman M, Ahlstedt S, Lilja G, van Hage Hamsten M. Quantification of IgE antibodies simplifies the classification of allergic diseases in 4-year-old children. A report from the prospective birth cohort study--BAMSE. Pediatr Allergy Immunol. 2003;14:441–447. doi:10.1046/j.0905-6157.2003.00079.x
  • Sperber CM, Samarasinghe SR, Lomax GP. An upper and lower bound of the medication possession ratio. Patient Prefer Adherence. 2017;11:1469–1478. doi:10.2147/PPA.S136890
  • Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl. 1980;59:44–47. doi:10.2340/00015555924447
  • Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol. 2004;24:147–174. doi:10.1146/annurev.immunol.24.021605.090720
  • Blanchard C, Rotehnberg ME. Biology of the eosinophil. Adv Immunol. 2009;101:81–121.
  • Takatsu K. Interleukin-5 and IL-5 receptor in health and diseases. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(8):463–485. doi:10.2183/pjab.87.463
  • Rothenberg ME. Eosinophilia. N Engl J Med. 1998;338(22):1592–1600. doi:10.1056/NEJM199805283382206
  • Lee HK, Pyun BY, Lee SJ. Etiologic allergens, blood eosinophil count and total IgE level according to age and site of skin lesion in atopic dermatitis. J Asthma Allergy Clin Immunol. 1992;12:70–77.
  • Sacco O, Sale R, Silvestri M, et al. Total and allergen-specific IgE levels in serum reflect blood eosinophilia and fractional exhaled nitric oxide concentrations but not pulmonary functions in allergic asthmatic children sensitized to house dust mites. Pediatr Allergy Immunol. 2003;14:475–481. doi:10.1046/j.0905-6157.2003.00092.x
  • Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. J Eur Acad Dermatol Venereol. 2018;32:657–682. doi:10.1111/jdv.14891
  • Wollenberg A, Barbarot S, Bieber T, et al. Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II. J Eur Acad Dermatol Venereol. 2018;32:850–878. doi:10.1111/jdv.14888
  • Abrahan A, Roga G. Topical steroid-damaged skin. Indian J Dermatol. 2014;59(5):456–459. doi:10.4103/0019-5154.139872
  • Mao C, Zhou Y, Ji D, et al. Chemical fingerprint of Dachaihu granule and its chemical correlation between raw herbs. J Chromatogr Sci. 2017;55(4):405–410.
  • Zhou HY, Shin EM, Guo LY, et al. Anti-inflammatory activity of 21(α, β)-methylmelianodiols, novel compounds from Poncirus trifoliata Rafinesque. Eur J Pharmacol. 2007;572(2–3):239–248. doi:10.1016/j.ejphar.2007.07.005
  • Lee YM, Kim DK, Kim SH, Shin TY, Kim HM. Antianaphylactic activity of Poncirus trifoliata fruit extract. J Ethnopharmacol. 1996;54(2–3):77–84. doi:10.1016/S0378-8741(96)01451-1
  • Park WH, Kang S, Piao Y, et al. Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB. J Ethnopharmacol. 2015;174(4):37–44. doi:10.1016/j.jep.2015.07.039
  • Naik SR, Bhagat S, Shah PD, Tare AA, Ingawale D, Wadekar RR. Evaluation of anti-allergic and anti-anaphylactic activity of ethanolic extract of Zizyphus jujuba fruits in rodents. Rev Bras Farmacogn. 2013;23(5):811–818. doi:10.1590/S0102-695X2013000500014
  • Chen BH, Wu PY, Chen KM, Fu TF, Wang HM, Chen CY. Antiallergic potential on RBL-2H3 cells of some phenolic constituents of Zingiber officinale (Ginger). J Nat Prod. 2009;72(5):950–953. doi:10.1021/np800555y
  • Goyal R, Sharma PL, Singh M. Possible attenuation of nitric oxide expression in anti-inflammatory effect of Ziziphus jujuba in rat. J Nat Med. 2011;65:514–518. doi:10.1007/s11418-011-0531-0
  • Mahluji S, Ostadrahimi A, Mobasseri M, Attari VE, Payahoo L. Anti-Inflammatory effects of Zingiber Officinale in type 2 diabetic patients. Adv Pharm Bull. 2013;3(2):273–276. doi:10.5681/apb.2013.044
  • Zhou YX, Gong XH, Zhang H, Peng C. A review on the pharmacokinetics of paeoniflorin and its anti-inflammatory and immunomodulatory effects. Bio Pharmaco. 2020;130:110505. doi:10.1016/j.biopha.2020.110505
  • Chen R, Qi QL, Wang MT, Li QY. Therapeutic potential of naringin: an overview. Pharm Biol. 2016;54(12):3203–3210. doi:10.1080/13880209.2016.1216131
  • Yao Q, Lin MT, Zhu YD, Xu HL, Zhao YZ. Recent trends in potential therapeutic applications of the dietary flavonoid Didymin. Molecules. 2018;23(10):2547. doi:10.3390/molecules23102547
  • Abe H, Sakaguchi M, Odashima S, Arichi S. Protective effect of saikosaponin-d isolated from Bupleurum falcatum L. on CCl4-induced liver injury in the rat. Naunyn Schmiedebergs. Arch Pharmacol. 1982;320:266–271. doi:10.1007/BF00510139